Prevest Denpro Ltd Stock Price Today (NSE: PREVEST)

Prevest Denpro Ltd

388.100.95 (0.24%)
Market Closed

Fundamental Score

...

Prevest Denpro Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Prevest Denpro Ltd share price today is 388.10, down 0.24% on NSE/BSE as of 18 June 2026. Prevest Denpro Ltd (PREVEST) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of 521.17 (Cr). The 52-week high for PREVEST share price is 620.99 and the 52-week low is 318.15. At a P/E ratio of 26.18x, PREVEST is currently trading below its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 18.74% and a debt-to-equity ratio of 0.00.

Prevest Denpro Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
442.25
Low
371.00
Volume
4.6K
Change
-5.88%

Prevest Denpro Ltd share price chart: -5.88% return over the past month. 52-week high ₹620.99, 52-week low ₹318.15.

Prevest Denpro Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
390.00390.00388.10388.102.00K (Cr)
392.90392.90387.25389.052.00K (Cr)
409.95414.30393.20393.204.60K (Cr)
393.00410.00390.00408.0024.40K (Cr)
400.00400.00385.00386.552.20K (Cr)
403.95403.95395.00396.656.60K (Cr)
390.05394.95390.05394.851.20K (Cr)
397.95399.00390.00390.054.00K (Cr)
394.70394.70390.70390.70800.00 (Cr)
395.00395.00371.00384.508.00K (Cr)

Prevest Denpro Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
392.90392.90387.25388.10-1.22%
435.95435.95371.00393.20-9.81%
364.70459.95349.95440.00+20.65%
452.00467.80318.15341.80-24.38%
440.05481.70427.00452.55+2.84%
491.50514.00424.50437.50-10.99%
440.45512.00425.10491.50+11.59%
530.00530.00429.90440.30-16.92%
543.20559.90486.00524.45-3.45%
564.03620.99540.40543.00-3.73%
548.00592.99520.00564.03+2.93%
471.85619.90466.00546.00+15.71%

Returns & Performance

Good

Return on Equity (ROE)

18.74%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

25.25%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

36.63%

Average operating profit margin over 5 years

Dividend Yield

0.23%

Annual dividend as % of current share price

Prevest Denpro Ltd Valuation Check

Excellent

Price to Earnings (P/E)

26.18x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

47.87x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

73.60%

% shares held by company founders/management

Poor

FII Holding

0.63%

% shares held by foreign institutional investors

Poor

DII Holding

0.75%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Average

Profit Growth (Quarterly YoY)

15.08%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

14.76%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

22.80%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-61.33%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

29.49%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.00x

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

26.29 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Prevest Denpro Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of PREVEST across key market metrics for learning purposes.

Positive Indicators

10 factors identified

Strong Return on Equity (18.74%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (25.25%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (36.63%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Attractive Valuation (P/E: 26.18 vs Industry: 47.87)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Consistent Growth Track Record (22.80% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (29.49% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Cash Generation (₹26.29 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (73.60%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

2 factors identified

Weak Earnings Growth (-61.33% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Limited Institutional Interest (FII+DII: 1.38%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

Prevest Denpro Ltd vs Medical Equipment & Supplies Peers

Peer Comparison - Medical Equipment & Supplies

Compare Prevest Denpro Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
68.5/100
388
₹521.17
26.2
Average
18.74%
Good
25.25%
Excellent
0.0
Excellent
29.49%
Excellent
22.80%
Excellent
0.23%
60.7/100
1330
₹19506.20
53.9
Average
15.77%
Good
20.08%
Excellent
0.1
Excellent
28.38%
Excellent
19.44%
Excellent
0.18%
31.7/100
37
₹3162.93
157.5
Average
0.70%
Poor
1.08%
Poor
0.1
Excellent
0.01%
68.7/100
243
₹1488.44
57.8
Average
21.88%
Excellent
19.20%
Good
0.0
Excellent
57.51%
Excellent
9.81%
Good
0.00%
42.1/100
497
₹1363.11
50.1
Average
30.08%
Excellent
31.14%
Excellent
0.6
Good
0.00%
13.8/100
215
₹1224.98
59.6
Average
4.75%
Poor
6.91%
Poor
0.6
Good
0.00%
60.3/100
173
₹633.93
25.8
Average
36.78%
Excellent
31.12%
Excellent
0.5
Good
90.06%
Excellent
61.82%
Excellent
0.00%
61.2/100
413
₹354.57
34.2
Average
13.58%
Average
16.35%
Good
0.4
Excellent
74.11%
Excellent
13.69%
Good
0.00%
47.7/100
187
₹294.37
32.7
Average
13.56%
Average
18.45%
Good
0.0
Excellent
0.00%
Nureca Ltd...
NURECA543264
36/100
272
₹292.61
71.2
Average
-1.12%
Poor
-0.90%
Poor
0.0
Excellent
1.98%
Average
0.00%
29.6/100
85
₹189.41
15.4
Average
14.36%
Average
16.60%
Good
0.6
Good
0.51%

Prevest Denpro Ltd PE Ratio History

Historical price-to-earnings ratio for PREVEST — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202413.45₹589.1043.8x
FY 202313.09₹418.0031.9x
FY 20229.64₹360.5037.4x
FY 20218.16₹433.7553.2x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Prevest Denpro Ltd Dividend History

Annual cash dividends paid by PREVEST — dividend yield 0.23%

Financial YearDividends Paid (₹ Cr)
FY 20251.20 Cr
FY 20240.32 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Prevest Denpro Ltd Quarterly Performance

Latest quarterly metrics for PREVEST — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

14.76%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

15.08%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

22.80%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

29.49%

Compounded annual net profit growth over 5 years

Prevest Denpro Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for PREVEST — calculated from daily price history

40RSI 14
Neutral — RSI 40

Momentum is balanced — neither overbought nor oversold.

SMA 50
407
▼ Price below SMA 50 — Short-term bearish
SMA 200
478
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
8K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Prevest Denpro Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Prevest Denpro Ltd (PREVEST) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Prevest Denpro Ltd

About PREVEST (Prevest Denpro Ltd)

Prevest Denpro Ltd is a dynamic force in the medical equipment and supplies sector, specializing in crafting innovative dental solutions. Driven by a commitment to oral healthcare ...advancement, Prevest Denpro meticulously engineers and manufactures a broad spectrum of dental materials and equipment. These offerings range from essential consumables utilized in daily dental practices to sophisticated tools designed to enhance precision and efficiency. Their dedication to research and development is evident in their constantly evolving product line, reflecting a proactive approach to addressing the ever-changing needs of dental professionals worldwide. The company's core philosophy revolves around providing high-quality, reliable, and accessible solutions that contribute to improved patient outcomes and streamlined workflows within dental clinics and laboratories. The company’s portfolio encompasses a diverse range of products catering to every facet of modern dentistry. Dentists can rely on Prevest Denpro for restorative procedures, utilizing their advanced composites and cements that boast excellent aesthetics and durability. Root canal treatments are supported by their specialized endodontic materials, designed for effective disinfection and obturation. Orthodontists benefit from their comprehensive selection of orthodontic adhesives, brackets, and wires. The company also delivers a variety of impression materials, ensuring accurate and detailed replicas for crown, bridge, and denture fabrication. This comprehensive approach positions Prevest Denpro as a single-source solution for dental professionals seeking to optimize their practice and provide the highest level of care to their patients. Beyond product excellence, Prevest Denpro emphasizes building strong relationships with its distributors and end-users. Through continuous education, training programs, and responsive technical support, the company strives to empower dental professionals with the knowledge and skills needed to effectively utilize their products. A global presence allows Prevest Denpro to serve a diverse clientele, adapting its offerings to meet the specific needs and preferences of different markets. With a unwavering focus on quality, innovation, and customer satisfaction, Prevest Denpro continues to solidify its position as a trusted partner in the dental community, consistently pushing the boundaries of what's possible in oral healthcare.

Company Details

Symbol:PREVEST
Industry:Medical Equipment & Supplies
Sector:Medical Equipment & Supplies

Key Leadership

Mr. Atul Modi
MD & Chairman
Ms. Namrata Modi
CFO & Whole Time Director
Mr. Aman Sadhotra
Company Secretary & Compliance Officer

PREVEST Share Price: Frequently Asked Questions

What is the current share price of Prevest Denpro Ltd?

Prevest Denpro Ltd (PREVEST) trades at ₹388.10 on NSE and BSE. Market cap ₹521.17 (Cr). Educational data only.

What is the P/E ratio of Prevest Denpro Ltd?

Prevest Denpro Ltd has a P/E of 26.18x vs industry average 47.87x.

What is the Bull Run score for Prevest Denpro Ltd?

Prevest Denpro Ltd has a Bull Run score of 68.5/100 based on 25+ financial parameters.

Does Prevest Denpro Ltd pay dividends?

Prevest Denpro Ltd has a dividend yield of 0.23%. Past dividends don't guarantee future payments.

What is the ROE of Prevest Denpro Ltd?

Prevest Denpro Ltd has ROE of 18.74%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Prevest Denpro Ltd?

Prevest Denpro Ltd has debt-to-equity of 0.00.

Is Prevest Denpro Ltd a good investment?

Bull Run gives Prevest Denpro Ltd a score of 68.5/100. This is not investment advice — consult a SEBI-registered advisor.